Facts
The French Triathlon Federation (Fédération Française de Triathlon, FFTri) charges respondent M117 for a violation of the Anti-Doping Rules. During a triathlon on June 19, 2011, a sample was collected for doping control purposes. The analysis of the sample showed the presence of triamcinolone. Triamcinolone is a prohibited substance according the World Anti-Doping Agency (WADA) prohibited list and is regarded as a specified substance.
History
The respondent used a pharmaceutical product against chronic back pain. This product was the cause of the positive test.
The panel regards this as a case of self medication.
Decision
1. The decision is a period of ineligibility of two years in which respondent can't take part in competition and manifestation organized or authorized by the FFTri as pronounced in the decision, dated September 6, 2011, by the disciplinary committee of the FFTri and extended to all relevant French sport federations.
2. The present decision will start on the date of notification.
5. The decision will be published and sent to the parties involved.
